Despite Alzheimer’s disease being the sixth–leading cause of death in the United States, there is still no treatment or cure. People living with Alzheimer’s and dementia (PLWD) are a vulnerable population who often are given poor quality care leading to “higher rates of hospitalization, more emergency department visits, adverse health outcomes, premature institutionalization, and wasted resources,” according to Leading Age.
To tackle this issue, a five-year grant totaling $53.4 million was awarded to Brown University and Hebrew SeniorLife, by National Institute on Aging (NIA), to create treatments to improve health care and quality of life for PLWD by conducting trials in the field.
The trial, Imbedded Pragmatic Alzheimer’s Disease and AD-Related Dementias Clinical Trials (IMPACT) Collaboratory, has initiative plans to improve quality of life for PLWD by:
- Developing best-practice research methods.
- Designing and implementing pragmatic trials in the field.
- Training researchers and investigators.
- Building collaborative relationships among researchers, health care providers, senior living communities, and other stakeholders.
- Ensuring people in the studies are culturally diverse and include under-represented backgrounds.